Stacey Knobler joined the Sabin Vaccine Institute in 2018 to lead an initiative dedicated to accelerating the development of a universal influenza vaccine. Stacey has more than 20 years of experience as a global health and development professional, with expertise in research, program design and implementation, and strategic planning. She previously served as a Senior Adviser and Scientific Program Director for multiple large-scale initiatives for the Division of International Epidemiology and Population Studies at the Fogarty International Center (FIC), within the U.S. National Institutes of Health (NIH).
Stacey has been recognized for her leadership of research and outreach activities that have effectively engaged stakeholders from multiple sectors, integrated numerous academic disciplines and translated scientific findings for application within a broad range of communities. Stacey has received numerous awards for outstanding achievement and distinguished service to the U.S. Institute of Medicine and the National Academy of Sciences, as well as the FIC Director’s Outstanding Service Award and the FIC Director’s Special Award for Mentorship. She has over 40 professional publications and has served on the editorial review committees of several public health and infectious disease journals. Stacey is currently the President of the Board for the American Friends of the London School of Hygiene and Tropical Medicine. She received bachelor’s degrees in molecular genetics and political science from the University of Rochester in New York, and master’s degrees in epidemiology and public health from the London School of Hygiene and Tropical Medicine.